MENU
+Compare
KTTA
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$1.30
Change
-$0.05 (-3.70%)
Capitalization
1.65M

KTTA Pasithea Therapeutics Corp Forecast, Technical & Fundamental Analysis

Industry Biotechnology
KTTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for KTTA with price predictions
Feb 21, 2025

KTTA sees MACD Histogram just turned negative

KTTA saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on February 06, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 35 instances where the indicator turned negative. In of the 35 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on February 06, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on KTTA as a result. In of 64 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

KTTA moved below its 50-day moving average on February 06, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KTTA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for KTTA entered a downward trend on February 04, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 14 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where KTTA advanced for three days, in of 117 cases, the price rose further within the following month. The odds of a continued upward trend are .

KTTA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.092) is normal, around the industry mean (12.496). P/E Ratio (0.000) is within average values for comparable stocks, (84.451). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.603). KTTA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.000) is also within normal values, averaging (251.218).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. KTTA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KTTA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
KTTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

KTTA is expected to report earnings to -17 cents per share on August 30

Pasithea Therapeutics Corp KTTA Stock Earnings Reports
Q2'23
Est.
$-0.17
Q1'23
Est.
$-0.17
Q4'22
Est.
$-0.18
Q3'22
Missed
by $0.03
Q2'22
Est.
$-0.11
The last earnings report on May 31 showed earnings per share of -17 cents, meeting the estimate of -17 cents. With 47.52K shares outstanding, the current market capitalization sits at 1.65M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1111 Lincoln Road
Phone
+1 702 514-4174
Employees
8
Web
https://www.pasithea.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AGRI1.660.01
+0.61%
AgriFORCE Growing Systems Ltd
LUCK10.64-0.01
-0.05%
Lucky Strike Entertainment Corporation
MIDD167.07-2.85
-1.68%
Middleby Corp
BMR2.90-0.11
-3.65%
Beamr Imaging Ltd
ARMN3.81-0.18
-4.51%
Aris Mining Corp

KTTA and Stocks

Correlation & Price change

A.I.dvisor tells us that KTTA and FATE have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KTTA and FATE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KTTA
1D Price
Change %
KTTA100%
-3.70%
FATE - KTTA
32%
Poorly correlated
-8.09%
ACET - KTTA
25%
Poorly correlated
-2.66%
SPRB - KTTA
24%
Poorly correlated
-1.20%
TRAW - KTTA
24%
Poorly correlated
-4.48%
HEPA - KTTA
24%
Poorly correlated
-9.20%
More